Ipsos : Helped by a technical support level
Entry price | Target | Stop-loss | Potential |
---|
€46.62 |
€53 |
€44 |
+13.69% |
---|
The technical support around 45.78 EUR emanating from daily closing prices could trigger a technical rebound for Ipsos shares.
Summary● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.75 for the current year.
● With regards to fundamentals, the enterprise value to sales ratio is at 0.93 for the current period. Therefore, the company is undervalued.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
● The group usually releases upbeat results with huge surprise rates.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.